Confident from conducting high-quality men’s health studies across multiple GCP-compliant sites in the Mumbai metropolitan area, Vedic took on a few more projects. Noteworthy was a study for VigRX Plus, a supplement that was already doing well through e-commerce. Seventy-eight men aged 25–50 years of age, with mild to moderate erectile dysfunction (ED), participated in this RCT. VigRX Plus was well tolerated and more effective than a placebo in improving sexual function in men. The study results were widely viewed online even today, helped the sponsor defend their claims and generate good returns on their study investment. As usual, the study sites and data were monitored by team monitors (clinical research associates) and all trial-related activities audited by an independent quality assurance manager.
